L. Caturla and F. Barbé, Sex and age-related differences in doxapram pharmacokinetics in neonates. A population pharmacokinetic analysis, 2004.

B. Larroque and G. Bréart, Survival of very preterm infants: Epipage, a population based cohort study, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.89, issue.2, pp.139-144, 2004.
DOI : 10.1136/adc.2002.020396

R. Martin and A. Fanaroff, Neonatal apnea, bradycardia, or desaturation: Does it matter?, The Journal of Pediatrics, vol.132, issue.5, pp.758-767, 1998.
DOI : 10.1016/S0022-3476(98)70297-5

J. Hascoët and M. Boutroy, Traitement des apn??es du pr??matur??, Archives de P??diatrie, vol.5, issue.5, pp.546-52, 1998.
DOI : 10.1016/S0929-693X(99)80321-2

J. Zhao, F. Gonzalez, and D. Mu, Apnea of prematurity: from cause to treatment, European Journal of Pediatrics, vol.136, issue.1, pp.1097-105, 2011.
DOI : 10.1016/S1569-9048(03)00041-7

J. Hascoet, Risks end Benefits of Therapies for Apnoea in Premature Infants, Drug Saf, pp.363-79, 2000.

J. Abu-shaweesh and R. Martin, Neonatal Apnea: What's New? Pediatr Pulmonol, pp.937-981, 2008.
DOI : 10.1002/ppul.20832

URL : http://onlinelibrary.wiley.com/doi/10.1002/ppul.20832/pdf

O. Mathew, Apnea of prematurity: pathogenesis and management strategies, Journal of Perinatology, vol.27, issue.5, pp.302-312, 2010.
DOI : 10.1542/peds.2004-0326

H. Tamim, . Consanguinity, . Apnea, and . Prematurity, Consanguinity and Apnea of Prematurity, American Journal of Epidemiology, vol.158, issue.10, pp.942-948, 200315.
DOI : 10.1093/aje/kwg226

E. Bloch-salisbury, M. Hall, P. Sharma, T. Boyd, F. Bednarek et al., Heritability of Apnea of Prematurity: A Retrospective Twin Study, PEDIATRICS, vol.126, issue.4, pp.779-787, 201013.
DOI : 10.1542/peds.2010-0084

J. Hascoet, Le poumon du nouveau-né, Périnatologie. Doin, pp.231-237, 2000.

C. Poets, Apnea of prematurity: What can observational studies tell us about pathophysiology?, Sleep Medicine, vol.11, issue.7, pp.701-708, 2010.
DOI : 10.1016/j.sleep.2009.11.016

L. Corvaglia and E. Mariani, Combined oesophageal impedance-pH monitoring in preterm newborn: comparison of two options for layout analysis, Neurogastroenterology & Motility, vol.51, issue.10, pp.1027-81, 2009.
DOI : 10.1111/j.1365-2982.2009.01301.x

L. Corvaglia, D. Zama, M. Spizzichino, A. Aceti, E. Mariani et al., The frequency of apneas in very preterm infants is increased after non-acid gastro-esophageal reflux, Neurogastroenterology & Motility, vol.111, issue.4, pp.303-152, 2011.
DOI : 10.1542/peds.111.4.e355

T. Omari, Apnea-Associated Reduction in Lower Esophageal Sphincter Tone in Premature Infants, The Journal of Pediatrics, vol.154, issue.3, pp.374-382, 2009.
DOI : 10.1016/j.jpeds.2008.09.009

B. Vergales, Characterization of Periodic Breathing in Preterm Infants

D. Gold and . Montgolfier-aubron, Hyper-réactivité vagale du nouveau-né et du nourrisson : vraie entité ou faux problème ? Journées des Techniques Avancées en gynécologie obstétrique, infertilité, néonatologie, pédiatrie et sage-femme, 1999.

E. Deykin, M. Bauman, D. Kelly, C. Hsieh, and D. Shannon, Apnea of Infancy and Subsequent Neurologic, Cognitive, and Behavioral Status, Pediatrics, vol.173, pp.638-683, 1984.

L. Wang, Shared Events on the Risk of Cystic Periventricular Leukomalacia and Cerebral Palsy in Preterm Infants

M. Greene, Impact of Bradycardia on Neurodevelopmental Outcome in ELBW Infants

G. Pichler, B. Urlesberger, and W. Müller, Impact of bradycardia on cerebral oxygenation and cerebral blood volume during apnoea in preterm infants, Physiological Measurement, vol.24, issue.3, pp.671-80, 2003.
DOI : 10.1088/0967-3334/24/3/304

B. Urlesberger, A. Kaspirek, G. Pichler, and W. Müller, Apnoea of Prematurity and Changes in Cerebral Oxygenation and Cerebral Blood Volume, Neuropediatrics, vol.30, issue.01, pp.29-33, 1999.
DOI : 10.1055/s-2007-973453

T. Apnea and P. , Prolonged Infantile Apnea: 1985, Pediatrics, vol.176, pp.129-160, 1985.

C. Bonanno and R. Wapner, Antenatal Corticosteroids in the Management of Preterm Birth: Are We Back Where We Started?, Obstetrics and Gynecology Clinics of North America, vol.39, issue.1, pp.47-63, 2012.
DOI : 10.1016/j.ogc.2011.12.006

D. Roberts and S. Dalziel, Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth, Cochrane Database Syst Rev, vol.3, 2006.

L. Corvaglia and A. Aceti, In preterm infants with recurrent apnoea, methylxanthine reduces the number of episodes and the use of mechanical ventilation in the short term; caffeine is also associated with improved longer term outcomes, Evidence-Based Medicine, vol.16, issue.4, pp.120-121, 201129.
DOI : 10.1136/ebm1207

D. Henderson-smart and P. Steer, Methylxanthine treatment for apnea in preterm infants, Cochrane Database Syst.Rev, vol.135, issue.4, 2010.
DOI : 10.1002/14651858.CD000074.pub2

D. Henderson-smart, D. Paoli, and A. , Methylxanthine treatment for apnoea in preterm infants, Cochrane Database of Systematic Reviews, vol.135, issue.4, 2010.
DOI : 10.1002/14651858.CD000140

J. Kuzemko and J. Paala, Apnoeic attacks in the newborn treated with aminophylline., Archives of Disease in Childhood, vol.48, issue.5, pp.404-410, 1973.
DOI : 10.1136/adc.48.5.404

D. Henderson-smart and P. Davis, Prophylactic methylxanthines for endotracheal extubation in preterm infants, Cochrane Database of Systematic Reviews, vol.39, issue.1, 2010.
DOI : 10.1002/14651858.CD000139

L. Rhein, Extended Use of Caffeine Decreases Intermittent Hypoxia in Preterm Infants

D. Henderson-smart and P. Steer, Caffeine versus theophylline for apnea in preterm infants, Cochrane Database of Systematic Reviews, vol.3, issue.1, 2010.
DOI : 10.1002/14651858

G. Fuglsang, K. Nielsen, K. Nielsen, L. Sennels, F. Jakobsen et al., The Effect of Caffeine Compared with Theophylline in the Treatment of Idiopathic Apnea in Premature Infants, Acta Paediatrica, vol.33, issue.5, pp.786-794, 1989.
DOI : 10.1007/BF00606424

A. Bairam, M. Boutroy, Y. Badonnel, and P. Vert, Theophylline versus caffeine: Comparative effects in treatment of idiopathic apnea in the preterm infant, The Journal of Pediatrics, vol.110, issue.4, pp.636-645, 1987.
DOI : 10.1016/S0022-3476(87)80569-3

T. Lee, C. B. Steer, P. Flenady, V. Shearman, and A. , Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity*, Clinical Pharmacology & Therapeutics, vol.71, issue.6, pp.628-668, 1997.
DOI : 10.1002/cpt1979254447

L. Doyle, Neonatal Caffeine Treatment Reduces Rates of Developmental Co- Ordination Disorder (DCD) at Five Years of Age in Children Wheighing less than 1251 g at Birth : Results from the Cafeeine for Apnea of Prematurity (CAP) Trial. E- PAS20131165

F. Marchal, A. Bairam, and P. Vert, Neonatal apnea and apneic syndromes, Clin Perinatol, vol.14, pp.509-538, 1987.

M. Edraki, H. Pourpulad, M. Kargar, N. Pishva, N. Zare et al., Olfactory stimulation by vanillin prevents apnea in premature newborn infants, Iran J Pediatr, vol.23, pp.261-269, 2013.

L. Joseph, S. Goldberg, and E. Picard, CO2 treatment for apnea, The Journal of Pediatrics, vol.154, issue.4, pp.627-635, 2009.
DOI : 10.1016/j.jpeds.2008.12.031

S. Al-saif, R. Alvaro, J. Manfreda, K. Kwiatkowski, D. Cates et al., A Randomized Controlled Trial of Theophylline Versus CO2 Inhalation for Treating Apnea of Prematurity, The Journal of Pediatrics, vol.153, issue.4, pp.513-521, 2008.
DOI : 10.1016/j.jpeds.2008.04.025

D. Berterottière, D. 'allest, A. Dehan, M. Gaultier, and C. , Effects of increase in body temperature on the breathing pattern in premature infants, J Dev Physiol, vol.13, pp.303-311, 1990.

B. Bohnhorst, K. Cech, C. Peter, and M. Doerdelmann, Oral versus Nasal Route for Placing Feeding Tubes: No Effect on Hypoxemia and Bradycardia in Infants with Apnea of Prematurity, Neonatology, vol.98, issue.2, pp.143-152, 2010.
DOI : 10.1159/000279617

B. Bohnhorst, Skin to Skin Care in the Neonatal Intensive Care Unit: More Data Regarding Seriously Ill Infants Are Badly Needed, Neonatology, vol.97, issue.4, pp.318-338, 2010.
DOI : 10.1159/000255164

M. Filippa, E. Devouche, C. Arioni, M. Imberty, and M. Gratier, Live maternal speech and singing have beneficial effects on hospitalized preterm infants, Acta Paediatrica, vol.10, issue.10, pp.1017-1037, 2013.
DOI : 10.1097/ANC.0b013e3181cc3c69

URL : https://hal.archives-ouvertes.fr/hal-01480095

K. Rand, Preferential Physiologic Response to Maternal Voice and Heartbeat across Different Gestational Ages

D. Paoli, A. Davis, P. Faber, B. Morley, and C. , Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates, Cochrane Database Syst Rev, issue.1, p.2977, 2008.

B. Lemyre, P. Davis, D. Paoli, and A. , Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity, Cochrane Database of Systematic Reviews, vol.135, issue.3, p.2272, 2002.
DOI : 10.1016/S0022-3476(99)70180-0

C. Roberts, P. Davis, and L. Owen, Neonatal Non-Invasive Respiratory Support: Synchronised NIPPV, Non-Synchronised NIPPV or Bi-Level CPAP: What Is the Evidence in 2013, Neonatology, vol.104, issue.3, pp.203-212, 2013.
DOI : 10.1159/000353448

. Dopram®, Base de données Thériaque, Centre National Hospitalier d'Informations sur le médicament, 2012.

C. Yost, A New Look at the Respiratory Stimulant Doxapram, CNS Drug Reviews, vol.23, issue.1, pp.3-4236, 2006.
DOI : 10.1016/S0006-8993(02)03181-5

. Martindale, The ExtraPharmacopoeia, pp.363-364, 1982.

M. Ishikawa, Induction of hepatic cytochrome P-450 and drug metabolism by doxapram in the mouse, pp.109-121, 1991.

A. Bairam, P. Blanchard, K. Mullahoo, K. Beharry, N. Laudignon et al., Pharmacodynamic Effects and Pharmacokinetic Profiles of Keto-Doxapram and Doxapram in Newborn Lambs, Pediatric Research, vol.28, issue.2, pp.142-148, 1990.
DOI : 10.1203/00006450-199008000-00013

P. Riddell and G. Robertson, USE OF DOXAPRAM AS AN AROUSAL AGENT IN OUTPATIENT GENERAL ANAESTHESIA, British Journal of Anaesthesia, vol.50, issue.9, pp.921-925, 1978.
DOI : 10.1093/bja/50.9.921

J. Davies, BLIND NASAL INTUBATION USING DOXAPRAM HYDROCHLORIDE, British Journal of Anaesthesia, vol.40, issue.5, pp.361-365, 1968.
DOI : 10.1093/bja/40.5.361

W. Houser and D. Schlueter, Prolonged Doxapram Infusion in Obesity-Hypoventilation Syndrome, JAMA: The Journal of the American Medical Association, vol.239, issue.4, pp.340-341, 197823.
DOI : 10.1001/jama.1978.03280310072026

R. Coutts, F. Jamali, F. Malek, A. Peliowski, and N. Finer, Urinary metabolites of doxapram in premature neonates, Xenobiotica, vol.344, issue.10, pp.1407-1425, 1991.
DOI : 10.1016/S0378-4347(00)82043-5

F. Jamali, R. Coutts, F. Malek, N. Finer, and A. Peliowski, Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity, Dev Pharmacol Ther, vol.16, pp.78-82, 1991.

F. Hayakawa, S. Hakamada, K. Kuno, T. Nakashima, and Y. Miyachi, Doxapram in the treatment of idiopathic apnea of prematurity: Desirable dosage and serum concentrations, The Journal of Pediatrics, vol.109, issue.1, pp.138-178, 1986.
DOI : 10.1016/S0022-3476(86)80594-7

H. Kumita, S. Mizuno, M. Shinohara, T. Ichikawa, and T. Yamazaki, Low-Dose Doxapram Therapy in Premature Infants and Its CSF and Serum Concentrations, Acta Paediatrica, vol.80, issue.8-9, pp.786-91, 1991.
DOI : 10.1021/jm00326a004

D. Henderson-smart and P. Steer, Doxapram treatment for apnea in preterm infants, Cochrane Database Dyst. Rev, issue.4, p.75, 2000.

C. Maillard, M. Boutroy, J. Fresson, F. Barbé, and J. Hascoët, QT interval lengthening in premature infants treated with doxapram, Clinical Pharmacology & Therapeutics, vol.70, issue.6, pp.540-545, 2001.
DOI : 10.1016/S0009-9236(01)95877-1

J. Tay-uyboco, K. Kwiatkowski, D. Cates, B. Seifert, S. Hasan et al., Clinical and Physiological Responses to Prolonged Nasogastric Administration of Doxapram for Apnea of Prematurity, Neonatology, vol.59, issue.4, pp.190-200, 1991.
DOI : 10.1159/000243342

C. Fischer, C. Ferdynus, J. Gouyon, and D. Semama, Doxapram and hypokalaemia in very preterm infants: Table??1, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.11, issue.(4), pp.416-424, 2013.
DOI : 10.1007/s004670050260

J. Gershanik, B. Boecler, H. Ensley, S. Mccloskey, and W. George, The Gasping Syndrome and Benzyl Alcohol Poisoning, New England Journal of Medicine, vol.307, issue.22, pp.1384-1392, 1982.
DOI : 10.1056/NEJM198211253072206

W. Brown, N. Buist, H. Gipson, R. Huston, and N. Kennaway, FATAL BENZYL ALCOHOL POISONING IN A NEONATAL INTENSIVE CARE UNIT, The Lancet, vol.319, issue.8283, p.1250, 1982.
DOI : 10.1016/S0140-6736(82)92377-7

K. Barrington and S. Muttitt, Randomized, controlled, blinded trial of doxapram for extubation of the very low birthweight infant, Acta Paediatrica, vol.145, issue.2, pp.191-195, 2007.
DOI : 10.1016/S0022-3476(86)80786-7

K. Barrington, N. Finer, G. Torok-both, F. Jamali, and R. Coutts, Dose-Response Relationship of Doxapram in the Therapy for Refractory Idiopathic Apnea of Prematurity, Pediatrics, vol.180, pp.22-29, 1987.

F. Eyal, G. Alpan, E. Sagi, B. Glick, O. Peleg et al., Aminophylline Versus Doxapram in Idiopathic Apnea of Prematurity: A Double-Blind Controlled Study, Pediatrics, vol.175, pp.709-722, 1985.

C. Hunt, R. Inwood, and D. Shannon, Respiratory and nonrespiratory effects of doxapram in congenital central hypoventilation syndrome, Am Rev Respir Dis, vol.119, pp.263-272, 1979.

T. Yamazaki, M. Kajiwara, K. Itahashi, and M. Fujimura, Low-dose doxapram therapy for idiopathic apnea of prematurity, Pediatrics International, vol.11, issue.2, pp.124-131, 2001.
DOI : 10.1159/000457668

M. Bénard, M. Boutroy, I. Glorieux, and C. Casper, Enqu??te sur l'utilisation du doxapram dans les unit??s de n??onatologie en France, Archives de P??diatrie, vol.12, issue.2, pp.151-156, 2005.
DOI : 10.1016/j.arcped.2004.10.024

M. Boutroy, Pharmacology and use of methylxanthines and doxapram for the treatment of neonatal apnoeas, Paediatric Clinical Pharmacology, Evelyne Jacqz- Aigrain, Imti Choonara, pp.214-220, 2006.

F. Barbe, C. Hansen, Y. Badonnel, H. Legagneur, P. Vert et al., Severe Side Effects and Drug Plasma Concentrations in Preterm Infants Treated With Doxapram, Therapeutic Drug Monitoring, vol.21, issue.5, pp.547-52, 1999.
DOI : 10.1097/00007691-199910000-00011

M. Ozaki, M. Ishikawa, Y. Takayanagi, and K. Sasaki, Sex-related Differences in Rat Liver Microsomal Enzymes and Their Induction by Doxapram, Journal of Pharmacy and Pharmacology, vol.38, issue.11, pp.975-983, 1993.
DOI : 10.1016/0163-7258(88)90007-1

P. Yudkin, M. Aboualfa, J. Eyre, C. Redman, and A. Wilkinson, New birthweight and head circumference centiles for gestational ages 24 to 42 weeks, Early Human Development, vol.15, issue.1, pp.45-52, 1987.
DOI : 10.1016/0378-3782(87)90099-5

R. Kliegman, Neonatal necrotizing enterocolitis: Bridging the basic science with the clinical disease, The Journal of Pediatrics, vol.117, issue.5, pp.833-838, 1990.
DOI : 10.1016/S0022-3476(05)83354-2

R. Kliegman, Models of the pathogenesis of necrotizing enterocolitis, The Journal of Pediatrics, vol.117, issue.1, pp.2-5, 1990.
DOI : 10.1016/S0022-3476(05)81123-0

D. Villiers, G. Walele, A. Van-der-merwe, P. Kalis, and N. , Second-degree atrioventricular heart block after doxapram administration, The Journal of Pediatrics, vol.133, issue.1, pp.149-50, 1998.
DOI : 10.1016/S0022-3476(98)70197-0

I. Hamon and V. Valdes, Diff??rences li??es au sexe dans le m??tabolisme du glutathion (GSH) du grand pr??matur??, Archives de P??diatrie, vol.18, issue.3, pp.247-52, 2011.
DOI : 10.1016/j.arcped.2010.12.004